Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne Gamper

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Neurourology and Urodynamics|March 28, 2017
Re: Sheng W, Zhang H, Kirschner-Hermanns R. Could urinary nerve growth factor be a biomarker for overactive bladder? A meta-analysis. Neurourol Urodyn. 2017;9999:1-8. doi: 10.1002/nau.23210Marianne Gamper, Volker Viereck
Biotechniques|March 25, 2005
Strategy for chromosomal gene targeting in RecA-deficient Escherichia coli strainsMarianne Gamper, Peter Kast
Archives of Gynecology and Obstetrics|July 1, 2026
One-year outcome after laser treatment of vulvar lichen sclerosus: a prospective observational trialMarianne Gamper, Irena Zivanovic, Helena Bischofberger, et al.
The Journal of Urology|July 6, 2016
Sensory Hyperinnervation Distinguishes Bladder Pain Syndrome/Interstitial Cystitis from Overactive Bladder SyndromeSigrid Regauer, Marianne Gamper, Mathias K Fehr, et al.
The Journal of Urology|January 18, 2015
Are mast cells still good biomarkers for bladder pain syndrome/interstitial cystitis?Marianne Gamper, Sigrid Regauer, JoEllen Welter, et al.
The FEBS Journal|January 19, 2005
Characterization of the secreted chorismate mutase from the pathogen Mycobacterium tuberculosisSeverin Sasso, Chandra Ramakrishnan, Marianne Gamper, et al.
International Urogynecology Journal|December 13, 2019
Erbium:YAG laser treatment of female stress urinary incontinence: midterm dataAndrzej Kuszka, Marianne Gamper, Claudia Walser, et al.
Menopause (New York, N.Y.)|February 25, 2025
A randomized controlled trial to evaluate a novel dual laser therapy for vulvar lichen sclerosus: exploratory study assessing the impact of menopausal statusIrena Zivanovic, Marianne Gamper, Debra Fesslmeier, et al.
Archives of Gynecology and Obstetrics|May 5, 2023
Nd:YAG/Er:YAG dual laser vs. topical steroid to treat vulvar lichen sclerosus: study protocol of a randomized controlled trialVolker Viereck, Marianne Gamper, Sigrid Regauer, et al.
Therapeutische Umschau. Revue Therapeutique|May 23, 2019
[Acute and recurrent urinary tract infections in women presenting in primary practice]Julia Münst, Marlies von Siebenthal, Claudia Walser, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Neurourology and Urodynamics|March 28, 2017
Re: Sheng W, Zhang H, Kirschner-Hermanns R. Could urinary nerve growth factor be a biomarker for overactive bladder? A meta-analysis. Neurourol Urodyn. 2017;9999:1-8. doi: 10.1002/nau.23210Marianne Gamper, Volker Viereck
Biotechniques|March 25, 2005
Strategy for chromosomal gene targeting in RecA-deficient Escherichia coli strainsMarianne Gamper, Peter Kast
Archives of Gynecology and Obstetrics|July 1, 2026
One-year outcome after laser treatment of vulvar lichen sclerosus: a prospective observational trialMarianne Gamper, Irena Zivanovic, Helena Bischofberger, et al.
The Journal of Urology|July 6, 2016
Sensory Hyperinnervation Distinguishes Bladder Pain Syndrome/Interstitial Cystitis from Overactive Bladder SyndromeSigrid Regauer, Marianne Gamper, Mathias K Fehr, et al.
The Journal of Urology|January 18, 2015
Are mast cells still good biomarkers for bladder pain syndrome/interstitial cystitis?Marianne Gamper, Sigrid Regauer, JoEllen Welter, et al.
The FEBS Journal|January 19, 2005
Characterization of the secreted chorismate mutase from the pathogen Mycobacterium tuberculosisSeverin Sasso, Chandra Ramakrishnan, Marianne Gamper, et al.
International Urogynecology Journal|December 13, 2019
Erbium:YAG laser treatment of female stress urinary incontinence: midterm dataAndrzej Kuszka, Marianne Gamper, Claudia Walser, et al.
Menopause (New York, N.Y.)|February 25, 2025
A randomized controlled trial to evaluate a novel dual laser therapy for vulvar lichen sclerosus: exploratory study assessing the impact of menopausal statusIrena Zivanovic, Marianne Gamper, Debra Fesslmeier, et al.
Archives of Gynecology and Obstetrics|May 5, 2023
Nd:YAG/Er:YAG dual laser vs. topical steroid to treat vulvar lichen sclerosus: study protocol of a randomized controlled trialVolker Viereck, Marianne Gamper, Sigrid Regauer, et al.
Therapeutische Umschau. Revue Therapeutique|May 23, 2019
[Acute and recurrent urinary tract infections in women presenting in primary practice]Julia Münst, Marlies von Siebenthal, Claudia Walser, et al.
Pageof 3